Osteopore(OSX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

OSX.AU Osteopore

Trading 12-19 14:09:51 AEDT

0.01

+0.00

0.00%

High0.01	Low0.01	Vol797.24K
Open0.01	D1 Closing0.01	Amplitude14.29%
Mkt Cap1.91M	Tradable Cap1.45M	Total Shares272.50M
T/O5.93K	T/O Rate0.38%	Tradable Shares207.85M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"OSX.AU","market":"AU","secType":"STK","nameCN":"Osteopore","latestPrice":0.007,"timestamp":1766113644784,"preClose":0.007,"halted":0,"volume":797241,"delay":0,"nameEN":"Osteopore","floatShares":207851789,"shares":272501807,"eps":-0.029897,"marketStatus":"Trading","change":0,"latestTime":"12-19 14:09:51 AEDT","open":0.007,"high":0.008,"low":0.007,"amount":5925,"amplitude":0.142857,"askPrice":0.007,"askSize":15868,"bidPrice":0.006,"bidSize":6481869,"shortable":3,"etf":0,"ttmEps":-0.029897,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1766120400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.007,"openAndCloseTimeList":[[1766098800000,1766120400000]],"volumeRatio":5.629664,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/OSX.AU/wiki","defaultTab":"wiki","newsList":[{"id":"2586411450","title":"BUZZ-Australia's Osteopore gains on dental products distribution deal in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2586411450","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586411450?lang=en_us&edition=fundamental","pubTime":"2025-11-25 08:42","pubTimestamp":1764031375,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Osteopore gains on dental products distribution deal in Malaysia** Shares of Osteopore OSX.AX rise as much as 11.1% to A$0.010, rising most since September 24** Medical equipment make","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL4N3X1011:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSX.AU","BK7126"],"gpt_icon":0},{"id":"2586490033","title":"Osteopore Ltd - Strikes 5 Year Partnership With Dksh for Dental Product Distribution in Malaysia","url":"https://stock-news.laohu8.com/highlight/detail?id=2586490033","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586490033?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:29","pubTimestamp":1764019765,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nFWN3X008B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2567167720","title":"Kelyniam Global Inc. to Present at Life Sciences Virtual Investor Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2567167720","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567167720?lang=en_us&edition=fundamental","pubTime":"2025-09-15 12:01","pubTimestamp":1757908874,"startTime":"0","endTime":"0","summary":"Kelyniam Global Inc. is set to present at the Life Sciences Virtual Investor Forum on September 18th, 2025. The company, known for its custom cranial implants, will discuss its sales momentum and product line enhancements, including the CustomizedBone implant licensed from Finceramica Spa and the OsteoStrip and Osteoplug product lines from Osteopore. This online event will be interactive, allowing investors to ask questions in real-time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kelyniam Global Inc. published the original content used to generate this news brief via PR Newswire  on September 15, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nNDL27xyjm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KLYG","BK7126","OSX.AU"],"gpt_icon":0},{"id":"2566656732","title":"BUZZ-Australia's Osteopore jumps on partnership to develop bone implant","url":"https://stock-news.laohu8.com/highlight/detail?id=2566656732","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566656732?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:44","pubTimestamp":1757378654,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Osteopore jumps on partnership to develop bone implant** Shares of Osteopore OSX.AX rise as much as 30.4% to A$0.015, their highest level since July 29; last up 13%** Regenerative medicine co announces collaboration with Tan Tock Seng Hospital for the development of a novel implant for avascular necrosis ** AVN is a condition where bone tissue dies due to poor blood supply** About 23.7 mln shares traded, 6.8x the 30-day average** YTD stock down 62.9%, including current session's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL3N3UW00Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2566627655","title":"BRIEF-Osteopore Ltd Announces Collaboration For Avn Implant Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2566627655","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566627655?lang=en_us&edition=fundamental","pubTime":"2025-09-09 08:05","pubTimestamp":1757376329,"startTime":"0","endTime":"0","summary":"BRIEF-Osteopore Ltd Announces Collaboration For Avn Implant DevelopmentSept 9 (Reuters) - Osteopore Ltd OSX.AX:ANNOUNCES COLLABORATION FOR AVN IMPLANT DEVELOPMENTFurther company coverage: OSX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nFWN3UV1CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2566658379","title":"Osteopore Ltd - Announces Collaboration for Avn Implant Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2566658379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566658379?lang=en_us&edition=fundamental","pubTime":"2025-09-09 06:38","pubTimestamp":1757371087,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250908:nFWN3UV1CE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSX.AU","BK7126"],"gpt_icon":0},{"id":"2557149516","title":"Osteopore Begins Study on Wound Healing Effects of Polycaprolactone Membrane in Third Molar Surgery","url":"https://stock-news.laohu8.com/highlight/detail?id=2557149516","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557149516?lang=en_us&edition=fundamental","pubTime":"2025-08-08 10:39","pubTimestamp":1754620792,"startTime":"0","endTime":"0","summary":"Osteopore  began a clinical study with the Universiti Malaya in Malaysia for secondary socket healing in the third molar surgery site of the lower jaw, comparing the wound healing effects of Osteopore's polycaprolactone membrane against a commonly used collagen membrane, according to a Friday Australian bourse filing.The study obtained ethics approval, and it expects to recruit a total of 18 participants with a post-procedure follow-up period of six months.Patient recruitment is expected to begin immediately.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2556369870","title":"Osteopore Secures Vietnam Hospital Contracts For Orthopaedic Implants","url":"https://stock-news.laohu8.com/highlight/detail?id=2556369870","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556369870?lang=en_us&edition=fundamental","pubTime":"2025-08-04 13:15","pubTimestamp":1754284556,"startTime":"0","endTime":"0","summary":"Osteopore  has secured tender wins worth AU$90,000 in two major Vietnamese public hospitals, offering its flagship high tibial osteotomy  solution and bone grafting products, marking a strategic entry into the nation's fast-growing orthopaedic market, according to a Monday Australian bourse filing.The deals are expected to anchor the company in Vietnam's orthopedic market, forecast to grow at a 7.68% compound annual growth rate  through 2028 due to aging demographics and rising demand, the filing said.The Asia-Pacific HTO market is projected to grow at a 9.2% CAGR, reaching 35,000 procedures annually, while the bone grafting market is expected to expand at a 2.3% CAGR, with 250,000 procedures anticipated yearly over the same period, the filing added.The company will collaborate with its Vietnamese distribution partner to finalize supply and logistics arrangements with the hospitals within the next three months, per the filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAGR","LU0012050646.USD","BK7126","LU0106261612.USD","HTO","BK4159","OSX.AU","BK4172"],"gpt_icon":0},{"id":"2555702340","title":"Osteopore Ltd-Business Progress Update, Zimmer Biomet Sales Units Grows 3X","url":"https://stock-news.laohu8.com/highlight/detail?id=2555702340","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555702340?lang=en_us&edition=fundamental","pubTime":"2025-07-29 06:53","pubTimestamp":1753743200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250728:nTUE7ZY91H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2553426389","title":"Osteopore to Recruit First Patient for Jawbone Regeneration Trial After Research Governance Office Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2553426389","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553426389?lang=en_us&edition=fundamental","pubTime":"2025-07-21 14:25","pubTimestamp":1753079114,"startTime":"0","endTime":"0","summary":"Osteopore  said that its clinical trial for jawbone regeneration, to be conducted in partnership with Princess Alexandra Hospital, secured clearance from the Research Governance Office, with the first patient expected to be recruited in four weeks, according to a Monday Australian bourse filing.The single-arm feasibility study seeks to recruit at least 10 adult patients in Australia by 2028, and each patient will be assessed 36 months post-surgery.The trial will study the safety and tolerability of the firm's polycaprolactone-tricalcium phosphate scaffold for maxillomandibular reconstruction, used in combination with a vascularized corticoperiosteal tissue transfer.Its shares jumped over 15% on market close.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OSX.AU","XAO.AU","BK7126","XJO.AU","XKO.AU"],"gpt_icon":1},{"id":"2552752431","title":"First patient in QCH trial receives implant-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2552752431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552752431?lang=en_us&edition=fundamental","pubTime":"2025-07-17 07:00","pubTimestamp":1752706847,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250716:nASX8N1gCN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250716:nASX5XPPNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2551151314","title":"Becoming a substantial holder-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2551151314","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551151314?lang=en_us&edition=fundamental","pubTime":"2025-07-15 14:57","pubTimestamp":1752562621,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250715:nASX7Rx5vZ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250715:nASX4sl3tf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2551906160","title":"Application for quotation of securities - OSX-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2551906160","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551906160?lang=en_us&edition=fundamental","pubTime":"2025-07-14 16:26","pubTimestamp":1752481587,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250714:nASX7G719S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nASXb46shz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2551924960","title":"BRIEF-Osteopore Secures Market Approval In Switzerland Under European Union Medical Device Regulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2551924960","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2551924960?lang=en_us&edition=fundamental","pubTime":"2025-07-14 09:20","pubTimestamp":1752456047,"startTime":"0","endTime":"0","summary":"BRIEF-Osteopore Secures Market Approval In Switzerland Under European Union Medical Device RegulationJuly 14 (Reuters) - Osteopore Ltd OSX.AX:SECURES MARKET APPROVAL IN SWITZERLAND UNDER EUROPEAN UNION MEDICAL DEVICE REGULATIONFurther company coverage: OSX.AX ((Reuters.Briefs@thomsonreuters.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nFWN3TA009:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSX.AU","BK7126"],"gpt_icon":0},{"id":"2549586787","title":"Ceasing to be a substantial holder-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2549586787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549586787?lang=en_us&edition=fundamental","pubTime":"2025-07-07 15:58","pubTimestamp":1751875107,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250707:nASXbMKdTN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nASX6HzVvS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2547060399","title":"Change in substantial holding-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2547060399","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547060399?lang=en_us&edition=fundamental","pubTime":"2025-06-30 17:41","pubTimestamp":1751276470,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250630:nASX7lTJrm","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nASX48MZDb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2545402735","title":"Change in substantial holding-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2545402735","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545402735?lang=en_us&edition=fundamental","pubTime":"2025-06-24 16:54","pubTimestamp":1750755279,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250624:nASX6TGbQp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nASXb6nF74:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2545460367","title":"Becoming a substantial holder-OSX.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2545460367","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545460367?lang=en_us&edition=fundamental","pubTime":"2025-06-23 14:51","pubTimestamp":1750661495,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250623:nASX5JzBC","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nASX9jz80P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"2540867530","title":"Osteopore Launches Clinical Trial in Australia for Jawbone Reconstruction, Shares Jump 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540867530","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540867530?lang=en_us&edition=fundamental","pubTime":"2025-06-04 09:09","pubTimestamp":1748999344,"startTime":"0","endTime":"0","summary":"Osteopore  launched a clinical trial with Princess Alexandra Hospital for the reconstruction of jawbones in at least 10 adult patients, with the single-arm feasibility trial will be conducted in Australia, according to a Wednesday ASX filing.It plans to determine the safety and tolerability of polycaprolactone-tricalcium phosphate scaffolds with a vascularized corticoperiosteal tissue transfer. The technique, applied with the polycaprolactone-tricalcium phosphate scaffolds, was previously successfully employed in previous cranial and long-bone reconstruction trials.Patient recruitment for the maxillomandibular reconstruction trial is expected by 2028, and patient follow-up is expected to be 36 months post-surgery.The Human Research and Ethics Committee at Metro South Health provided clearance, while the firm expects clearance from the Research Governance Office.Its shares jumped 7% in recent trading on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OSX.AU","XAO.AU","BK7126","XJO.AU","XKO.AU"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.osteopore.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.2222},{"period":"3month","weight":-0.4167},{"period":"6month","weight":-0.3636},{"period":"1year","weight":-0.8108},{"period":"ytd","weight":-0.8}],"compareEarnings":[{"period":"1week","weight":0.0197},{"period":"1month","weight":0.0211},{"period":"3month","weight":0.049},{"period":"6month","weight":0.0914},{"period":"1year","weight":0.239},{"period":"ytd","weight":0.246}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications. It specializes in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist with the natural stages of bone healing. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; Osteomesh that is used in craniofacial surgery to repair various types of fractures; and Osteostrip for filling the void following a craniotomy. It operates in Singapore, Malaysia, South Korea, Vietnam, and internationally. The company was founded in 2003 and is headquartered in Singapore.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.137517},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.204464},{"month":3,"riseRate":0.666667,"avgChangeRate":0.127705},{"month":4,"riseRate":0,"avgChangeRate":-0.216795},{"month":5,"riseRate":0.5,"avgChangeRate":-0.118231},{"month":6,"riseRate":0.333333,"avgChangeRate":0.04764},{"month":7,"riseRate":0.333333,"avgChangeRate":0.154258},{"month":8,"riseRate":0,"avgChangeRate":-0.118778},{"month":9,"riseRate":0,"avgChangeRate":-0.091007},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.084531},{"month":11,"riseRate":0,"avgChangeRate":-0.077295},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.08469}],"exchange":"ASX","name":"Osteopore","nameEN":"Osteopore"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Osteopore(OSX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Osteopore(OSX.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Osteopore,OSX.AU,Osteopore股票,Osteopore股票老虎,Osteopore股票老虎国际,Osteopore行情,Osteopore股票行情,Osteopore股价,Osteopore股市,Osteopore股票价格,Osteopore股票交易,Osteopore股票购买,Osteopore股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Osteopore(OSX.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Osteopore(OSX.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}